These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34091123)

  • 1. Copper concentrations are prevalently associated with antithrombin III, but also with prothrombin time and fibrinogen in patients with liver cirrhosis: A cross-sectional retrospective study.
    Tarantino G; Citro V; Capone D; Gaudiano G; Sinatti G; Santini SJ; Balsano C
    J Trace Elem Med Biol; 2021 Dec; 68():126802. PubMed ID: 34091123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of fibrotic, haemostatic and endotoxic changes in patients with liver cirrhosis.
    Li CJ; Yang ZH; Lu FG; Shi XL; Liu DL
    Acta Gastroenterol Belg; 2018; 81(3):404-409. PubMed ID: 30350529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extent of diffuse intravascular coagulation and fibrinolysis in patients with liver cirrhosis.
    van Wersch JW; Russel MG; Lustermans FA
    Eur J Clin Chem Clin Biochem; 1992 May; 30(5):275-9. PubMed ID: 1627724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
    Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered coagulation protein content after albumin resuscitation.
    Lucas CE; Ledgerwood AM; Mammen EF
    Ann Surg; 1982 Aug; 196(2):198-202. PubMed ID: 6807224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin, fibrinogen, prothrombin and antithrombin III variations in blood, urines and liver in rat nephrotic syndrome (Heymann nephritis).
    Girot R; Jaubert F; Leon M; Bellon B; Aiach M; Josso F; Lepelletier O; Beguin S; Monnet JP
    Thromb Haemost; 1983 Feb; 49(1):13-7. PubMed ID: 6601862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of coagulation factors in severity categorization of hepatitis B-related liver cirrhosis].
    Li Q; Wang BE; Cong YL; Jia JD; Yin ZJ; Qian LX; Ma H
    Zhonghua Nei Ke Za Zhi; 2005 Mar; 44(3):188-90. PubMed ID: 15840257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.
    Scherer R; Kabatnik M; Erhard J; Peters J
    Intensive Care Med; 1997 Nov; 23(11):1150-8. PubMed ID: 9434921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changing characteristic of blood coagulation factors and their correlation with blood coagulation status in different hepatic diseases].
    Chen J; Duan ZP; Bai L; Zhao J; Ding M; Tong XY; Cong YL
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):206-10. PubMed ID: 22475141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic changes in patients with liver cirrhosis.
    Ho CH; Hou MC; Lin HC; Lee FY; Wu JC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):376-82. PubMed ID: 10389296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
    Zhang D; Hao J; Yang N
    J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography.
    Ben-Ari Z; Panagou M; Patch D; Bates S; Osman E; Pasi J; Burroughs A
    J Hepatol; 1997 Mar; 26(3):554-9. PubMed ID: 9075662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of haemostatic tests in chronic liver disease.
    Saray A; Mesihovic R; Vanis N; Gornjakovic S; Prohic D
    Med Arch; 2012; 66(4):231-5. PubMed ID: 22919876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
    Mormile A; Veglio M; Gruden G; Girotto M; Rossetto P; D'Este P; Cavallo-Perin P
    Acta Diabetol; 1996 Sep; 33(3):241-5. PubMed ID: 8904933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.